Ava, a medical technology company focused on innovations in women’s reproductive health and maker of the popular cycle tracking Ava bracelet, today announced it has raised $30 million in a strategic Series B funding round. The majority of Ava’s new financing came from existing investors, with prominent European VC firms btov and SVC also joining the round.